Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesZenith Capital Corporation

Zenith Capital Corporation

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.06 CAD 0.00(0%)
Last update at 2026-11-04T17:39:00Z
VOLUME
1000
Market Cap
16.00M

Momentum Score

…

Zenith Capital Corporation does not have significant operations. The company intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. Zenith Capital Corporation was incorporated in 2019 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.06
High
52 Week Price Range
0.10
Low
0.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Zenith Capital Corporation (ticker ZENI-P.V) are limited, preventing a clear profile of its core business or industry exposure. Because long-term growth drivers are not publicly documented, investors may only find potential attraction in issuer-specific characteristics that should be verified in official filings and regulatory statements.
The most important investment risk is the lack of transparent, accessible public information and likely low liquidity, which increases governance, operational and valuation uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-519.58%
Net Debt
4.40M
ROCE
318.33%
Diluted EPS TTM
-0.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax -13.10M -7.77M -6.88M -9.58M -11.30M
Net income -13.12M -7.80M -6.91M -9.63M -11.33M
Selling general administrative 2.83M 3.33M 2.07M 2.18M 2.79M
Reconciled depreciation 0.20M 0.19M 0.19M 0.22M 0.29M
Ebit - -0.12M -0.03M -0.07M -0.25M
Ebitda -12.60M -7.31M -6.57M -9.35M -10.87M
Operating income -11.16M -7.38M -6.67M -10.34M -11.16M
Interest expense 0.29M 0.27M 0.12M 0.01M 0.00M
Tax provision 0.02M 0.03M 0.03M 0.05M 0.03M
Interest income - - 0.10M - 0.01M
Net interest income -0.71M -0.51M -0.01M -0.11M 0.01M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 11.16M 7.38M 6.67M 10.34M 11.16M
Total other income expense net -1.22M 0.12M -0.20M 0.88M -0.16M
Net income from continuing ops -13.12M -7.80M -6.91M -9.63M -11.33M
Net income applicable to common shares - -0.14M -0.04M -0.09M -0.27M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets 3.17M 2.88M 3.33M 3.40M 3.92M
Intangible assets 1.00M 0.88M 0.78M 0.59M 1.34M
Other current assets 0.06M 0.01M 0.29M 0.05M 0.03M
Total liab 18.03M 16.72M 13.73M 14.16M 7.69M
Total stockholder equity -14.86M -13.84M -10.40M -10.76M -3.77M
Other current liab 0.18M 0.08M 0.26M 0.50M 0.92M
Common stock - 0.34M 0.33M 0.27M 0.15M
Capital stock 89.62M 80.94M 80.08M 75.64M 73.75M
Retained earnings -118.36M -0.39M -0.24M -0.20M -0.11M
Cash 0.03M 0.01M 0.01M 0.21M 0.21M
Total current liabilities 6.68M 0.01M 0.00M 0.00M 0.00M
Net debt 4.40M 3.47M 2.65M 0.38M -
Short long term debt 4.43M 3.48M 2.65M 0.59M -
Total current assets 1.38M 0.08M 0.21M 0.22M 0.14M
Net tangible assets - 0.07M 0.21M 0.22M 0.14M
Net receivables - 0.01M 0.00M 0.00M 0.00M
Inventory 0.11M 0.30M 0.63M 0.40M 0.38M
Accounts payable 2.07M 0.01M 0.00M 0.00M 0.00M
Non currrent assets other 0.70M 0.76M 0.55M 0.82M 0.32M
Non current assets total 1.79M 1.88M 1.69M 2.40M 2.29M
Capital lease obligations - - - 0.50M 0.92M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments -0.17M -0.26M -0.25M -0.37M -0.35M
Change to liabilities - 0.00M -0.00M 0.00M 0.00M
Total cash from financing activities 9.28M 0.01M 0.03M 0.15M 0.36M
Change to operating activities - - - - -0.04M
Net income -13.12M -0.14M -0.04M -0.09M -0.27M
Change in cash 0.02M -0.14M -0.01M 0.10M 0.30M
Begin period cash flow 0.01M 0.01M 0.21M 0.21M 1.16M
End period cash flow 0.03M 0.01M 0.01M 0.21M 0.21M
Total cash from operating activities -9.08M -0.15M -0.04M -0.05M -0.06M
Issuance of capital stock 8.11M 0.48M 5.45M 2.50M 4.84M
Depreciation 0.20M 0.19M 0.19M 0.22M 0.29M
Dividends paid 0.00M 0.00M 0.00M 0.00M -
Change to inventory 0.26M 0.30M 0.04M -0.00M -0.33M
Change to account receivables - -0.00M 0.00M -0.00M -0.00M
Change to netincome - - - 0.03M 0.24M
Capital expenditures 0.19M 0.16M 0.32M 0.32M 0.43M
Change in working capital -0.03M 3.97M -2.36M 6.49M 4.24M
Stock based compensation 1.84M 2.33M 1.01M 0.55M 1.17M
Other non cash items 2.06M 0.34M 0.07M -1.37M 0.14M
Free cash flow -9.28M -1.01M -8.25M -3.05M -5.94M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
ZENI-P
Zenith Capital Corporation		 -
-%		 0.06 - - - - -1.29
SHRX
Sharp Therapeutics Corp.		 -
-%		 1.37 - - - 32.37 -
NRX
NurExone Biologic Inc.		 -0.01
2.00%		 0.49 - 6.90 - 15.26 -7.24
MIR
MedMira Inc		 -
-%		 0.06 - - 223.37 - -80.03
TTI
Thiogenesis Therapeutics Corp.		 -
-%		 0.63 - - - 15.17 -58.16

Profile*

Zenith Capital Corporation

Zenith Capital Corporation does not have significant operations. The company intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. Zenith Capital Corporation was incorporated in 2019 and is headquartered in Vancouver, Canada.

400 ? 725 Granville Street, Vancouver, BC, Canada, V7Y 1G5

Name Title Year Born
Mr. Charalambos Katevatis Pres, CEO, CFO, Corp. Sec. & Director 1942

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…